Will recall of tablets impact Cadila?

Zydus Pharmaceuticals US Inc is recalling from the American market over 3.31 lakh bottles of Divalproex Sodium delayed release tablets used for the treatment of seizures and manic episodes in patients with bipolar disorder, latest Enforcement Report of the US Food and Drug Administration said. The tablets were manufactured by Ahmedabad-based Cadila Healthcare and are being recalled on account of failed dissolution specifications. Shares of Cadila will remain in focus.